Please login to the form below

Not currently logged in
Email:
Password:

Logimax

This page shows the latest Logimax news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Last year the Italian firm paid $300m to purchase AstraZeneca’s European rights to cardiovascular drug Seloken and related combination Logimax.

Latest news

  • Recordati acquires AstraZeneca blood pressure brands Recordati acquires AstraZeneca blood pressure brands

    Italian pharma firm obtains Seloken and Logimax. Recordati has picked up the rights to two of AstraZeneca’s hypertension treatments as part of a $300m (270m) deal. ... The agreement sees the Milan-based pharmaceutical group acquire rights to AZ’s

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...